Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension study of CT-P13 in patients with rheumatoid arthritis
jRCT1080222652Phase 4
- Sponsor
- Nippon Kayaku Co., Ltd.
- Start
- Nov 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of infliximab-dyyb in rheumatoid arthritis (RA), sponsored by Nippon Kayaku Co., Ltd.
02
Drugs
infliximab-dyyb
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCT1080222652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222652.